Showing results (51-60 of 95) with videos related to
Sort By:
Pageof 10
Clinical Lung Cancer|May 10, 2011
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutationsGabriella Farina, Flavia Longo, Olga Martelli, et al.Future Oncology (London, England)|November 29, 2017
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?Alessandra Fabi, Diana Giannarelli, Luca Moscetti, et al.Tumori|December 16, 2024
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, et al.European Journal of Cancer (Oxford, England : 1990)|July 12, 2023
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatmentsCarmine Valenza, Dario Trapani, Sara Gandini, et al.The Lancet. Oncology|July 26, 2013
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trialMarina Chiara Garassino, Olga Martelli, Massimo Broggini, et al.Journal of Cancer Research and Clinical Oncology|April 23, 2013
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancerClara Natoli, Patrizia Vici, Isabella Sperduti, et al.BJU International|February 28, 2012
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian surveyCristina Masini, Roberto Sabbatini, Camillo Porta, et al.Journal of Geriatric Oncology|February 6, 2014
Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancerUgo De Giorgi, Karim Rihawi, Michele Aieta, et al.Cancer Treatment Reviews|January 3, 2015
Triple positive breast cancer: a distinct subtype?Patrizia Vici, Laura Pizzuti, Clara Natoli, et al.Clinical Breast Cancer|December 3, 2014
Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian surveyNicola Tinari, Caterina Fanizza, Marilena Romero, et al.Pageof 10